Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay
Version of Record online: 2 SEP 2009
© 2009 Japanese Cancer Association
Volume 100, Issue 12, pages 2261–2267, December 2009
How to Cite
Inoue, K., Yoshida, M., Takahashi, M., Fujimoto, H., Shibutani, M., Hirose, M. and Nishikawa, A. (2009), Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay. Cancer Science, 100: 2261–2267. doi: 10.1111/j.1349-7006.2009.01342.x
- Issue online: 11 NOV 2009
- Version of Record online: 2 SEP 2009
- (Received June 29, 2009/Revised August 18, 2009/Accepted August 23, 2009/Online publication September 30, 2009)
- 1A 13-week subchronic toxicity study of madder color in F344 rats. Food Chem Toxicol 2008; 46: 241–52., , et al.
- 2One-year chronic toxicity of madder color in F344 rats – induction of preneoplastic/neoplastic lesions in the kidney and liver. Food Chem Toxicol 2008; 46: 3303–10., , et al.
- 3Induction of kidney and liver cancers by the natural food additive madder color in a two-year rat carcinogenicity study. Food Chem Toxicol 2009; 47: 184–91., , et al.
- 4A review of acute toxicity and genotoxicity data on natural food additives (in Japanese). Toxicol Forum 1985; 8: 91–105., , et al.
- 5Mutagenicity of natural food additives in Salmonella typhimurium. Report no. II (in Japanese). Ann Rep Nagoya City Public Health Res Inst 1984; 30: 53–7., , .
- 6Mutagenicity of anthraquinone and benzanthrone derivatives in the Salmonella/microsome test: activation of anthraquinone glycosides by enzymic extracts of rat cecal bacteria. Mutat Res 1979; 66: 9–24., .
- 7Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat Res 1992; 265: 263–72., , , , .
- 8The mutagenic constituents of Rubia tinctorum. Chem Pharm Bull 1992; 40: 1504–9., , .
- 9Identification of a mutagenic substance, in Rubia tinctorum L. (madder) root, as lucidin. Mutat Res 1983; 121: 185–90., .
- 10The genotoxicity of lucidin, a natural component of Rubia tinctorum L. and lucidinethylether, a component of ethanolic Rubia extracts. Cell Biol Toxicol 1988; 4: 225–39., , , , .
- 11Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 1990; 240: 1–12., , , , , .
- 12Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L. Carcinogenesis 1998; 19: 2163–8., , .
- 13Evaluation of DNA-binding activity of hydroxyanthraquinones occurring in Rubia tinctorum L. Carcinogenesis 1991; 12: 1265–71., , et al.
- 14Mutagenicity of natural anthraquinones from Rubia tinctorum in the Drosophila wing spot test. Planta Med 2001; 67: 127–31., , .
- 15Possible contribution of rubiadin, a metabolite of madder color, to renal carcinogenesis in rats. Food Chem Toxicol 2009; 47: 752–9., , et al.
- 16The mutagenic potential of madder root in dyeing processes in the textile industry. Mutat Res 2006; 605: 22–9., , , , , .
- 17Medium-term-liver and multiorgan carcinogenesis bioassays for carcinogens and chemopriventive agents. Exp Toxicol Pathol 1996; 48: 113–9., , , , .
- 18Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat Res 1991; 248: 239–60., .
- 19Advantages and limitations of stereological estimation of placental glutathione S-transferase-positive rat liver cell foci by computerized three-dimensional reconstruction. Jpn J Cancer Res 1989; 80: 326–30., , , , .
- 20Promotion potential of madder color in a medium-term multi-organ carcinogenesis bioassay model in F344 rats. J Food Sci 2008; 73: T26–32., , et al.
- 21Rubiadin, a new antioxidant from Rubia cordifolia. Indian J Biochem Biophys 1997; 34: 302–6., , .
- 22Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. J Ethnopharmacol 2006; 103: 484–90., , , .
- 23Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55–71..
- 24Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Human Pathol 1991; 22: 287–94., , , , .
- 25Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991; 51: 1564–7., , et al.
- 26Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 2001; 61: 1874–8., , et al.
- 27Tumor formation is correlated with expression of ß-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci 2004; 95: 316–20., , et al.
- 28Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 2003; 24: 107–11., , et al.